IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Onconova Therapeutics Inc

CUSIP: 68232V116 | 13 institutional holders

Quarters

Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2021

Virtu Financial LLC27,719
0.0% of portfolio›$5
UBS Group AG13,171
0.0% of portfolio›$2
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Virtu Financial LLC
27,719$50.0%GARPVery HighNew York, NY2021-09-17
UBS Group AG
13,171$20.0%CoreMediumZurich, Switzerland2021-08-13
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2021-08-13